Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies

BACKGROUND: Alpha-particle-emitting radiotherapies are of great interest for the treatment of disseminated cancer. Actinium-225 ((225)Ac) produces four α-particles through its decay and is among the most attractive radionuclides for use in targeted radiotherapy applications. However, supply issues f...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou, Diane S., Zerkel, Patrick, Robben, James, McLaughlin, Mark, Hazlehurst, Tim, Morse, David, Wadas, Thaddeus J., Pandya, Darpan N., Oyama, Reiko, Gaehle, Gregory, Nickels, Michael L., Thorek, Daniel L.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242709/
https://www.ncbi.nlm.nih.gov/pubmed/35695807
http://dx.doi.org/10.1089/cbr.2022.0010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242709/
https://www.ncbi.nlm.nih.gov/pubmed/35695807
http://dx.doi.org/10.1089/cbr.2022.0010

Ejemplares similares